A Study to Evaluate the Effects of Mavacamten in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Mavacamten
Related studies linked through entity extraction aliases.
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE3
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Status
- RECRUITING
- Phase
- N/A
A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
- Status
- COMPLETED
- Phase
- PHASE2